AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 31,020 | 16,487 | 4,124 | 0 | 16,459 |
| Gross Profit | 31,020 | 16,487 | 4,124 | N/A | 16,459 |
| Operating Expenses | 90,517 | 76,219 | 78,364 | 86,445 | 81,799 |
| Operating Income | -59,496 | -59,732 | -74,241 | -86,445 | -65,340 |
| Interest Expense | 151 | 196 | 372 | 636 | 196 |
| Other Income | 1,815 | -471 | 484 | 7,219 | -509 |
| Pre-tax Income | -57,832 | -60,399 | -74,129 | -79,862 | -66,045 |
| Income Tax | 3 | 11 | 14 | 3 | N/A |
| Net Income Continuous | -57,836 | -60,410 | -74,142 | -79,865 | -66,045 |
| Net Income | $-57,836 | $-60,410 | $-74,142 | $-79,865 | $-66,045 |
| EPS Basic Total Ops | -0.58 | -0.71 | -0.89 | -1.06 | -0.92 |
| EPS Basic Continuous Ops | -0.58 | -0.71 | -0.89 | -1.07 | -0.92 |
| EPS Diluted Total Ops | -0.58 | -0.71 | -0.89 | -1.06 | -0.92 |
| EPS Diluted Continuous Ops | -0.58 | -0.71 | -0.89 | -1.07 | -0.92 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.71 | -0.89 | -1.06 | -0.92 |
| EBITDA(a) | $-57,040 | $-57,265 | $-71,769 | $-83,812 | $-63,242 |